SFX by Ex Libris Inc.

Title:	Intestinal Lymphatic Transport Enhances the Post-Prandial Oral Bioavailability of a Novel Cannabinoid Receptor Agonist Via Avoidance of First-Pass Metabolism
Source:	Pharmaceutical Research [0724-8741] Trevaskis, Natalie yr:2009

Basic

Full text

Full text available via SpringerLINK Contemporary 1997-Present

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Trevaskis, Natalie L L. "Bile increases intestinal lymphatic drug transport in the fasted rat." Pharmaceutical research 22.11 (2005): 1863-70.
description	2.	Porter, Christopher J H H. "Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs." Nature reviews. Drug discovery 6.3 (2007): 231-248.
description	3.	Trevaskis Natalie L, N. "An examination of the interplay between enterocyte-based metabolism and lymphatic drug transport in the rat." Drug metabolism and disposition 34.5 (2006): 729-733.
description	4.	TREVASKIS, Natalie L. "Lipid-based delivery systems and intestinal lymphatic drug transport: A mechanistic update." Advanced Drug Delivery Reviews 60.6 (2008): 702-16.
description	5.	Garzon-Aburbeh, A. "1,3-dipalmitoylglycerol ester of chlorambucil as a lymphotropic, orally administrable antineoplastic agent." Journal of medicinal chemistry 26.8 (1983): 1200-3.
description	6.	Pouton, Colin W W. "Formulation of poorly water-soluble drugs for oral administration: Physicochemical and physiological issues and the lipid formulation classification system." European journal of pharmaceutical sciences 29.3-4 (2006): 278-287.
description	7.	Jandacek, Ronald J. "Tissue uptake of DDT is independent of chylomicron metabolism." Archives of toxicology 80.4 (2006): 196-200.
description	8.	Porter, CJH H. "Uptake of drugs into the intestinal lymphatics after oral administration." Advanced Drug Delivery Reviews 25.1 (1997): 71-89.
description	9.	Pouton, Colin W. "Formulation of lipid-based delivery systems for oral administration: Materials, methods and strategies." Advanced Drug Delivery Reviews 60.6 (2008): 625-37.
description	10.	Charman, Colin N. "Strategies to Address Low Drug Solubility in Discovery and Development." Pharmacological reviews 65.1 (2013): 315-499.
description	11.	Nguyen, T.-H. H. "Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation." Journal of Pharmacy and Pharmacology 62.7 (2010): 856-865.
description	12.	Goldberg, M. "Challenges for the oral delivery of macromolecules." Nature reviews. Drug discovery 2.4 (2003): 289-295.
description	13.	Caliph, Suzanne M. "Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats." Journal of pharmaceutical sciences 89.8 (2000): 1073-1084.
description	14.	Berezina, Tamara L L. "Mesenteric lymph duct ligation decreases red blood cell alterations caused by acute pancreatitis." The American journal of surgery 190.5 (2005): 800-4.
description	15.	Sweeney, Mary Ellen E. "Ezetimibe: an update on the mechanism of action, pharmacokinetics and recent clinical trials." Expert Opinion on Drug Metabolism and Toxicology 3.3 (2007): 441-50.
description	16.	Porter, Christopher J H J. "Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs." Journal of pharmaceutical sciences 97.2 (2008): 995-1012.
description	17.	Sato, M. "LXR Agonist Increases the Lymph HDL Transport in Rats by Promoting Reciprocally Intestinal ABCA1 and apo A-I mRNA Levels." Lipids 43.2 (2007): 125-31.
description	18.	Jana, A. "Perylene-3-ylmethanol: Fluorescent Organic Nanoparticles as a Single-Component Photoresponsive Nanocarrier with Real-Time Monitoring of Anticancer Drug Release." Journal of the American Chemical Society 134.18 (2012): 7656-9.
description	19.	Trevaskis, N. "The Role of the Intestinal Lymphatics in the Absorption of Two Highly Lipophilic Cholesterol Ester Transfer Protein Inhibitors (CP524,515 and CP532,623)." Pharmaceutical research 27.5 (2010): 878-893.
description	20.	GARZONABURBEH, A. "A LYMPHOTROPIC PRODRUG OF L-DOPA - SYNTHESIS, PHARMACOLOGICAL PROPERTIES, AND PHARMACOKINETIC BEHAVIOR OF 1,3-DIHEXADECANOYL-2-[(S)-2-AMINO-3-(3,4-DIHYDROXYPHENYL)PROPANOYL]PROPANE-1,2,3-TRIOL." Journal of medicinal chemistry 29.5 (1986): 687-691.